Research And Application Progress Of Nasal Intermittent Positive Pressure Ventilation In Preterm Respiratory Distress Syndrome

Nasal continuous positive airway pressure (NCPAP) is first used in the treatmentof premature infant respiratory distress syndrome (RDS) mode of noninvasiverespiratory support, and has become the center of many conventional treatmentmeasures. In recent years, however, reported by nasal intermittent positive pressureventilation (NIPPV) possible for neonatal non-invasive respiratory support provides abetter choice, especially in the premature infant respiratory management of RDS.NIPPV is a new kind of noninvasive respiratory support mode, combines thecharacteristics of NCPAP and synchronized intermittent mandatory ventilationincluding the nasal synchronized intermittent mandatory ventilation and nasal dualchannel positive pressure ventilation. A recent meta-analysis showed that comparedwith NCPAP, NIPPV can reduce the demand for mechanical ventilation in prematureRDS and increase decannulation rate, reduce the incidence of bronchial pulmonarydysplasia, reduce mortality. NIPPV as a supplement to NCPAP, have better effectthan NCPAP. Synchronously NIPPV (SNIPPV) as the main ventilation mode onreducing the incidence of bronchial pulmonary dysplasia has good applicationprospect, with SNIPPV as secondary ventilation mode is used to support is better thanthat of NCPAP breathing after extubation. In this paper, the clinical application ofNIPPV in premature RDS background, the classification of NIPPV, indications,contraindications, mechanism of action, clinical application and nursing managementand future research is discussed.